Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.92%-2.7M | -44.91%-2.85M | -360.28%-17.53M | 43.02%-11.19M | 64.20%-2.63M | -340.60%-2.78M | 63.60%-1.97M | 39.03%-3.81M | -59.29%-19.65M | -7.36M |
| Net income from continuing operations | -11.93%-4.09M | 24.48%-3.84M | 14.97%-5.8M | 30.59%-19.01M | 63.29%-3.45M | 19.43%-3.65M | -6.89%-5.09M | 21.63%-6.82M | -35.61%-27.39M | ---9.39M |
| Operating gains losses | 77.27%-42.58K | 67.30%-194.45K | -26.12%496.48K | 92.99%-98.18K | 100.83%11.71K | -3,235.73%-187.3K | ---594.58K | --672K | ---1.4M | ---1.4M |
| Depreciation and amortization | 6.11%94.69K | 5.85%93.02K | 6.92%91.8K | 43.50%353.42K | -13.95%90.44K | 40.90%89.24K | 81.61%87.88K | 191.35%85.86K | 251.56%246.29K | --105.09K |
| Remuneration paid in stock | -17.60%67.01K | -97.83%46.09K | -97.85%33.98K | -29.01%3.79M | -99.18%11.28K | -96.27%81.33K | 97.80%2.12M | 121.30%1.58M | 1,364.26%5.34M | --1.38M |
| Other non cashItems | 6.35%527.02K | 90.40%559.21K | 347.87%1.54M | -98.86%31.62K | -978.42%-1.1M | 613.85%495.55K | 58.03%293.7K | -86.52%344.36K | 2,018.50%2.77M | --125.45K |
| Change In working capital | 89.05%742.48K | -59.96%484.69K | -4,277.12%-13.89M | 375.34%3.74M | -1.23%1.8M | -77.75%392.75K | 161.62%1.21M | 139.67%332.57K | -89.23%786.15K | --1.82M |
| -Change in receivables | -400.06%-395.46K | -68.09%221.86K | -187.67%-462.15K | 110.24%122.07K | -22.61%-1.23M | -75.34%131.79K | 150.61%695.19K | -19.17%527.15K | -407.21%-1.19M | ---1M |
| -Change in prepaid assets | -81.26%-214.53K | -8.82%93.13K | 725.26%596.07K | -243.27%-561.92K | -104.81%-450.37K | -119.43%-118.36K | 115.77%102.14K | -200.69%-95.33K | 87.25%-163.7K | ---219.9K |
| -Change in payables and accrued expense | -217.20%-364.66K | -264.96%-1.15M | -3,288.41%-6.84M | 107.60%4.07M | 17.70%3.26M | -68.37%311.14K | 143,452.88%696.7K | 88.75%-201.96K | -76.83%1.96M | --2.77M |
| -Change in other current liabilities | 290.34%209.26K | 195.45%25.79K | -277.70%-182.52K | -0.56%351.94K | 328.53%222.64K | -70.88%53.61K | -143.91%-27.02K | -50.07%102.71K | -23.34%353.93K | ---97.42K |
| -Change in other working capital | --1.32M | --1.48M | ---7M | -41.52%-242K | --0 | --0 | ---- | ---- | -71.00%-171K | --375.14K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.92%-2.7M | -44.91%-2.85M | -360.28%-17.53M | 43.02%-11.19M | 64.20%-2.63M | -340.60%-2.78M | 63.60%-1.97M | 39.03%-3.81M | -59.29%-19.65M | ---7.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -61.71%-43.62K | 32.20%-24.31K | 44.62%-22.23K | -507.77%-124.46K | 90.67%-21.48K | 54.25%-26.97K | -114.17%-35.86K | -160.27%-40.15K | 106.22%30.52K | -230.14K |
| Net PPE purchase and sale | ---1.38K | --0 | -10.56%-6.8K | 22.91%-11.54K | --0 | --0 | 35.74%-5.39K | -131.18%-6.15K | -95.89%-14.97K | ---1.95K |
| Net intangibles purchas and sale | -56.60%-42.24K | 20.22%-24.31K | 54.61%-15.43K | 53.98%-112.92K | 82.72%-21.48K | 52.66%-26.97K | -15.34%-30.47K | 9.83%-33.99K | 49.20%-245.37K | ---124.27K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --290.86K | ---103.93K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -61.71%-43.62K | 32.20%-24.31K | 44.62%-22.23K | -507.77%-124.46K | 90.67%-21.48K | 54.25%-26.97K | -114.17%-35.86K | -160.27%-40.15K | 106.22%30.52K | ---230.14K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 26.86M | -57.49%9.5M | -65.85%3.5M | 3M | 9,347.63%3M | 0 | 59.71%22.35M | 10.25M |
| Net issuance payments of debt | --0 | --0 | --26.86M | --0 | ---6M | --3M | --3M | --0 | 147.96%12.4M | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 81.75%9.48M | ---2.15M |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | 1,912.35%9.5M | --9.5M | --0 | --0 | --0 | --472.08K | --0 |
| Net other financing activities | ---- | ---- | ---9.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.00%2 | --0 | --26.86M | -57.49%9.5M | -65.85%3.5M | --3M | 9,347.63%3M | --0 | 59.71%22.35M | --10.25M |
| Net cash flow | ||||||||||
| Beginning cash position | 706.97%8.52M | 18,387.08%11.4M | -46.52%2.09M | 231.62%3.91M | -0.19%1.25M | -45.54%1.06M | -99.13%61.66K | 231.62%3.91M | 9,993.98%1.18M | --1.25M |
| Current changes in cash | -1,543.00%-2.75M | -389.56%-2.88M | 341.91%9.31M | -166.61%-1.82M | -68.26%844.75K | 127.55%190.24K | 119.40%994.25K | -165.37%-3.85M | 133.94%2.73M | --2.66M |
| End cash Position | 363.49%5.78M | 706.97%8.52M | 18,387.08%11.4M | -46.52%2.09M | -46.52%2.09M | -0.19%1.25M | -45.54%1.06M | -99.13%61.66K | 231.62%3.91M | --3.91M |
| Free cash from | 2.30%-2.75M | -43.54%-2.88M | -356.06%-17.55M | 43.14%-11.32M | 64.52%-2.66M | -306.89%-2.81M | 63.17%-2.01M | 38.79%-3.85M | -55.22%-19.91M | ---7.48M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.